neostigmine and Granulocytic Leukemia
neostigmine has been researched along with Granulocytic Leukemia in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Wohl, MA | 1 |
Wood, JK | 1 |
Other Studies
1 other study available for neostigmine and Granulocytic Leukemia
Article | Year |
---|---|
Chronic myeloid leukaemia and a myasthenic syndrome.
Topics: Adult; Bone Marrow; Bronchial Neoplasms; Busulfan; Carcinoma; Humans; Leukemia, Myeloid; Male; Muscu | 1979 |